SMTL ID : 3i5n.1

Crystal structure of c-Met with triazolopyridazine inhibitor 13

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x B2D: 7-methoxy-N-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]-1,5-naphthyridin-4-amine(Non-covalent)

B2D.1: 15 residues within 4Å: Chain A: I.37, V.45, A.61, L.93, L.110, P.111, Y.112, M.113, D.117, R.161, M.164, A.174, D.175, A.179, Y.183 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.37, A:A.61, A:D.117, A:D.175, A:Y.183, A:Y.183 Hydrogen bonds: A:M.113, A:D.175 pi-Stacking: A:Y.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Boezio, A.A. et al., Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors. Bioorg.Med.Chem.Lett. (2009)

Release Date

2010-01-12

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence